AVELUMAB

avelumab 200 mg/10 mL injection, 10 mL vial

AVELUMAB (13123Q)

avelumab 200 mg/10 mL injection, 10 mL vial
13123Q
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required (STREAMLINED)

Restriction  15485

Indication: Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer
Treatment phase: Maintenance therapy - Initial treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 800 mg # of repeats: 7 DPMA: $5,367.06 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)